Alnylam Pharmaceuticals, Inc. (ALNY)
415.20
-14.82
(-3.45%)
USD |
NASDAQ |
Dec 09, 16:00
415.20
0.00 (0.00%)
After-Hours: 18:26
Alnylam Pharmaceuticals Total Liabilities (Quarterly): 4.618B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Glaukos Corp. | 229.84M |
| Bristol Myers Squibb Co. | 78.29B |
| BridgeBio Pharma, Inc. | 2.921B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.852B |
| Shareholders Equity (Quarterly) | 233.89M |
| Debt to Equity Ratio | 11.86 |
| Current Ratio | 2.541 |
| Net Debt Paydown Yield | -0.02% |